RevMed

Home/Brands/BIOMERIEUX SA

BIOMERIEUX SA

Main Filters

BIOMERIEUX SA

BIOMERIEUX SA
CATALOG #	QTY	PRICE	DESCRIPTION
Etest® AMIKACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® AMOXI/CLAV 2/1	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® AMOXICILLIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® AMPI/SULB 2/1	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® AMPICILLIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® AZITHROMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® BENZYLPENICIL	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® BENZYLPENICIL	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFACLOR	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFEPIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFOTAXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFOTAXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFOXITIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTAZIDIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTAZIDIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTRIAXONE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTRIAXONE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFTRIAXONE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEFUROXIME	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CEPHALOTHIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CHLORAMPHENICOL	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CIPROFLOXACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® CLINDAMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® DAPTOMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® DORIPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® ERTAPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® ERYTHROMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® FLUCONAZOLE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® FLUCYTOSINE	0	-	Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® GENTAMICIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® IMIPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® ITRACONAZOLE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® LEVOFLOXACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® LINEZOLID	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® MEROPENEM	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® METRONIDAZOLE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® MINOCYCLINE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® MOXIFLOXACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® OFLOXACIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® OXACILLIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® PIP/TAZO/CON-4	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® PIPERACILLIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® QUINUPRI/DALFO	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® RIFAMPICIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TETRACYCLINE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TIC/CLAV-CON2	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TIGECYCLINE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TOBRAMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® TRIM/SULFA 1/19	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® VANCOMYCIN	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

318 Results

Results Per Page

Catalog #

Available

Starting At

Name

Company Name

Description

Etest® CEFTAZIDIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTRIAXONE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTRIAXONE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFOXITIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFOTAXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFOTAXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFEPIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFACLOR

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEPHALOTHIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® BENZYLPENICIL

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® BENZYLPENICIL

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AMPI/SULB 2/1

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AZITHROMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AMIKACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AMOXICILLIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AMPICILLIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® AMOXI/CLAV 2/1

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® DORIPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® DAPTOMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TIGECYCLINE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® ERTAPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® LINEZOLID

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® METRONIDAZOLE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® MOXIFLOXACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® QUINUPRI/DALFO

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® LEVOFLOXACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® RIFAMPICIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® ITRACONAZOLE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® VANCOMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TRIM/SULFA 1/19

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TIC/CLAV-CON2

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TETRACYCLINE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® TOBRAMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® PIPERACILLIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® PIP/TAZO/CON-4

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® OXACILLIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® OFLOXACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® MINOCYCLINE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® MEROPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® IMIPENEM

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® GENTAMICIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® FLUCYTOSINE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® FLUCONAZOLE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® ERYTHROMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CLINDAMYCIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CIPROFLOXACIN

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CHLORAMPHENICOL

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFUROXIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTAZIDIME

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® CEFTRIAXONE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 15 doubling dilutions for MIC determination.